Ladenburg Thalmann Financial Services’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$31K Buy
1,562
+802
+106% +$14.2K ﹤0.01% 3859
2019
Q3
$12K Buy
760
+300
+65% +$4.43K ﹤0.01% 4307
2019
Q2
$6K Hold
460
﹤0.01% 4645
2019
Q1
$9K Buy
460
+200
+77% +$3.71K ﹤0.01% 4427
2018
Q4
$4K Buy
+260
New +$4.27K ﹤0.01% 4680

Other funds holding MRNA

Ladenburg Thalmann Financial Services's MRNA Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Moderna (MRNA) stake by 106% in Q4 2019, buying an estimated $14.2K and bringing the position to 1,562 shares worth $31K. The position accounts for ﹤0.01% of the portfolio, ranked #3859.

Ladenburg Thalmann Financial Services first reported a position in MRNA in Q4 2018 and has held it in 5 quarters since. 159 funds tracked by Wall St. Rank hold MRNA as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 1,562 shares of Moderna worth $31K as of Q4 2019.
  • Ladenburg Thalmann Financial Services bought 802 Moderna shares in Q4 2019, an estimated $14.2K.
  • Moderna made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #3859 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Moderna in Q4 2018 and has held it in 5 quarters since.
  • 159 funds tracked by Wall St. Rank held Moderna as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.